Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Technology | 14.39% |
| 3 | Financials | 10.63% |
| 4 | Industrials | 9.92% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Shutterstock
SSTK
$209M
| $2.44M | ﹤0.01% |
+56,700
| New | +$2.21M |
|
|
TRHC
2227
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.43M | ﹤0.01% |
+86,700
| New | +$2.54M |
|
2228
Cumberland Pharmaceuticals
CPIX
$117M
| $2.43M | ﹤0.01% |
330,300
+14,295
| +5% | +$105K |
|
2229
Kewaunee Scientific
KEQU
$105M
| $2.43M | ﹤0.01% |
83,800
+6,000
| +8% | +$173K |
|
2230
Corvus Pharmaceuticals
CRVS
$1.26B
| $2.43M | ﹤0.01% |
234,200
+39,900
| +21% | +$511K |
|
|
YELL
2231
DELISTED
Yellow Corporation Common Stock
YELL
| $2.42M | ﹤0.01% |
+168,453
| New | +$2.22M |
|
|
AC
2232
DELISTED
Associated Capital Group
AC
| $2.42M | ﹤0.01% |
71,355
-20,703
| -22% | -$732K |
|
|
NSM
2233
DELISTED
Nationstar Mortgage Holdings
NSM
| $2.42M | ﹤0.01% |
130,800
+88,000
| +206% | +$1.61M |
|
2234
Collegium Pharmaceutical
COLL
$909M
| $2.42M | ﹤0.01% |
+130,800
| New | +$1.87M |
|
2235
Twin Disc
TWIN
$357M
| $2.42M | ﹤0.01% |
90,900
-27,700
| -23% | -$678K |
|
2236
Perion Network
PERI
$384M
| $2.41M | ﹤0.01% |
779,967
+106,900
| +16% | +$340K |
|
2237
Ascent Industries
ACNT
$132M
| $2.4M | ﹤0.01% |
179,500
+12,600
| +8% | +$170K |
|
|
ACET
2238
DELISTED
Aceto Corp
ACET
| $2.4M | ﹤0.01% |
232,700
-35,500
| -13% | -$373K |
|
2239
Mitsubishi UFJ Financial
MUFG
$260B
| $2.4M | ﹤0.01% |
329,900
-1,225,638
| -79% | -$8.35M |
|
2240
VSE Corp
VSEC
$6.64B
| $2.4M | ﹤0.01% |
49,500
-6,000
| -11% | -$308K |
|
2241
Chefs' Warehouse
CHEF
$4.6B
| $2.39M | ﹤0.01% |
116,800
+99,200
| +564% | +$1.98M |
|
|
BLPH
2242
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $2.39M | ﹤0.01% |
61,813
+12,480
| +25% | +$327K |
|
|
SNT
2243
Senstar Technologies
SNT
$42.5M
| $2.39M | ﹤0.01% |
471,860
-11,289
| -2% | -$52.6K |
|
2244
Tronox
TROX
$941M
| $2.38M | ﹤0.01% |
+116,300
| New | +$2.84M |
|
2245
Brown-Forman Class B
BF.B
$13B
| $2.38M | ﹤0.01% |
+54,219
| New | +$2.07M |
|
2246
Customers Bancorp
CUBI
$2.81B
| $2.38M | ﹤0.01% |
91,520
-31,000
| -25% | -$880K |
|
2247
Fortuna Silver Mines
FSM
$3.15B
| $2.37M | ﹤0.01% |
454,800
+389,700
| +599% | +$1.76M |
|
2248
NWPX Infrastructure Inc
NWPX
$1.12B
| $2.37M | ﹤0.01% |
124,000
-13,500
| -10% | -$250K |
|
2249
Dorchester Minerals
DMLP
$1.37B
| $2.37M | ﹤0.01% |
155,917
+2,359
| +2% | +$35.1K |
|
|
TNAV
2250
DELISTED
Telenav Inc.
TNAV
| $2.36M | ﹤0.01% |
429,400
+21,100
| +5% | +$118K |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.